Rilmenidine
Cat. No.：YN320050
| 产品名称: | Rilmenidine |
| CAS No.: | 54187-04-1 |
| Chemical Name: | N-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine |
| Synonyms: | |
| 分子量: | 180.25 |
| 分子式: | C₁₀H₁₆N₂O |
| SMILES: | C1(NC(C2CC2)C3CC3)=NCCO1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Rilmenidine 是一种新型的抗高血压药物和口服活性选择性 I1 咪唑啉受体 (I1 imidazoline receptor) 激动剂。Rilmenidine 是一种α2肾上腺素受体激动剂。Rilmenidine 诱导自噬 (autophagy)。Rilmenidine 可通过减少交感神经过度活跃而发挥中枢作用，并通过抑制 Na+/H+反向转运而在肾脏中发挥作用。Rilmenidine 可调节白血病细胞增殖，刺激促凋亡蛋白 Bax，从而诱导人白血病 K562 细胞线粒体通路的紊乱和凋亡。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Gomez, R.E., Ernsbarger, P., Feinland, G., et al.Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 areaEur. J. Pharmacol.195(2),181-191(1991)
Burke, S.L., Evans, R.G., and Head, G.A.Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertensionJ. Hypertens.29(5),945-952(2011)
Williams, A., Sarkar, S., Cuddon, P., et al.Novel targets for Huntington's disease in an mTOR-independent autophagy pathwayNat. Chem. Biol.4(5),295-305(2008)
